CTOs on the Move

American Competitiveness Institute

www.aciusa.org

 
American Competitiveness Institute is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.aciusa.org
  • 1 International Plz Ste 600
    Philadelphia, PA USA 19113
  • Phone: 610.362.1200

Executives

Name Title Contact Details

Similar Companies

The New York Foundling Hospital

The New York Foundling Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. The New York Foundling Hospital is based in New York, NY. You can find more information on The New York Foundling Hospital at www.nyfoundling.org

Hospital Physician Partners

As one of the largest and fastest-growing Emergency and Hospital Medicine groups in the nation, we partner with more than 5,000 world-class providers who treat more than 6 million patients annually. Physician-led, our team consists of motivated, personable, highly qualified people interested in putting the patient first. We’re committed to doing the right thing for the patients, physicians, and hospitals we serve. Which is why 98% of our physicians recommend us to colleagues and friends. William C. Schumacher, M.D., a board certified emergency medicine physician, formally founded the Schumacher Group in 1994. The philosophy behind Schumacher Group`s founding was based on his belief that there was a better way to deliver and manage emergency medical services in the hospital environment. That `better way` is embodied in our founding mission. The Schumacher Group became known as Schumacher Clinical Partners in 2016.

Fister Lauberth

Fister Lauberth is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Community Research Initiative

Community Research Initiative is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Glytec System

Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home. With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment – including those with and without a diagnosis of diabetes.